Phenotypic Profiling via Time-Frequency Tissue-Response Spectroscopy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug screening methods using two-dimensional cell cultures often lead to false positives and false negatives due to their inability to accurately capture the complex, three-dimensional phenotypic responses of living tissues to drugs, resulting in inefficient new drug discovery processes.
Innovation Solution
The system employs motility contrast imaging and holographic optical coherence imaging to generate time-frequency tissue-response spectrograms, which are then analyzed using feature recognition and multi-dimensional scaling to create a phenotypic profile space that accurately maps and compares drug responses across different stimuli, doses, and conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If two-dimensional cell culture is used for drug screening, then the screening process is simple and fast, but the results produce false positives and false negatives due to inability to capture three-dimensional phenotypic responses
Solution Approach 1:
The patent transitions from two-dimensional monolayer cell culture to three-dimensional tissue culture models. This dimensional change allows cells to maintain their natural architecture, cell-cell interactions, and phenotypic responses, thereby improving measurement precision while maintaining screening capability through advanced imaging techniques.
Solution Approach 2:
The patent replaces traditional mechanical/chemical assay methods with optical imaging and computational analysis. By using light-based techniques to capture phenotypic responses and machine learning to analyze the data, the system achieves higher accuracy in three-dimensional cultures without proportionally increasing complexity.
2Measurement precision
If three-dimensional tissue culture is used for drug screening, then the phenotypic response accuracy is improved, but the imaging and analysis complexity increases
Solution Approach 1:
The patent employs a multi-functional integrated system that combines optical imaging, computational algorithms, and machine learning analysis into a unified platform. This universal approach handles multiple aspects of three-dimensional tissue analysis (structural, functional, dynamic) within a single system, managing complexity through integration rather than separate components.
Solution Approach 2:
The patent transforms complex three-dimensional imaging data into simplified phenotypic parameters through computational analysis. By changing the parameter representation from raw image data to extracted phenotypic features, the system reduces analysis complexity while maintaining measurement precision.
3Ease of operation
If traditional drug screening methods are used, then the process is straightforward, but false positives and false negatives occur due to oversimplified cellular responses
Solution Approach 1:
The patent implements feedback loops where phenotypic response data from three-dimensional cultures is continuously analyzed and used to refine drug predictions. The system learns from observed responses and adjusts its analysis, providing reliable feedback that improves both accuracy and operational simplicity over time through automated decision-making.
Solution Approach 2:
The patent introduces computational algorithms and machine learning models as intermediaries between the complex three-dimensional tissue responses and the final drug screening decisions. This intermediary layer translates complex biological data into actionable insights, maintaining ease of operation while improving reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the construction of a phenotype database that improves drug screening efficiency by accurately analyzing high-content phenotypic responses in three-dimensional tissue cultures, reducing the risk of false positives and negatives and enhancing the discovery of effective drugs.
Implementation Method 1
Motion is ubiquitous in all living things and occurs across broad spatial and temporal scales... When light scatters from an object that is displacing, the phase of the light is modified. If the light has coherence, then the motion-induced phase shifts of one light path interfere with the phase shifts of other light paths in constructive and destructive interference.
Implementation Method 2
If the light has coherence, then the motion-induced phase shifts of one light path interfere with the phase shifts of other light paths in constructive and destructive interference.
Implementation Method 3
low-coherence interferometry that can select light from specified depths by using coherence-gating approaches
Implementation Method 4
low-coherence interferometry that can select light from specified depths by using coherence-gating approaches
Data Source
AI summary
A phenotypic profiling method for drug/dose physiological response of living bodies utilizes feature recognition to segment the information in time-frequency tissue-response spectrograms to construct N-dimensional feature vectors. The feature vectors are used to generate a correlation matrix among a large number of different stimuli in the form of drugs, doses and conditions. Multi-dimensional scaling is applied to the correlation matrix to form a two-dimensional map of response relationships that retains rank distances from the higher-dimensionality feature matrix. The two-dimensional phenotypic profile space displays compact regions indicative of particular physiological responses, such as regions of enhanced active transport, membrane undulations and blebbing.